Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Psychooncology. 2020 Apr;29(4):719-728. doi: 10.1002/pon.5324. Epub 2020 Feb 11.
We performed a randomized controlled trial (RCT) to investigate whether regular screening with the distress thermometer (DT) by a nurse improved global quality of life (QOL) of patients with breast cancer (BC) treated with curative intent.
BC patients were randomized between regular screening for distress with a nurse-led DT intervention (NDTI) and usual care (UC). Both groups filled out questionnaires at baseline, after each received treatment modality and at follow-up visits up to 2 years. At these points, the intervention group received also the NDTI. The primary outcome was the global QOL of the EORTC QLQ C30 at 2 years after the end of treatment. Analyses were done on an intention-to-treat basis, using analysis of covariance (ANCOVA), generalized least squares, and interaction analyses.
Of 194 randomized patients, 153 filled out the questionnaires up to 2 years after treatment. There was no significant difference between NDTI and UC in global QOL 2 years after the end of treatment (mean diff. = -1∙273, P = .610; 95% CI [-6.195; 3.649]). Subgroup analysis of patients who received multimodality treatment (surgery, radiotherapy, and chemotherapy, n = 66) showed a significant between-group difference in global QOL over time (mean diff. = -10, P < .001; 95% CI [-14.835; -5.167]) together with other secondary outcome measures in favor of the NDTI.
NDTI did not lead to a significant improvement in global QOL 2 years after the end of treatment for patients with BC. However, the findings indicate that BC patients who received multimodality treatment may benefit from NDTI.
我们进行了一项随机对照试验(RCT),以研究护士定期使用痛苦温度计(DT)筛查是否能改善有治愈意图的乳腺癌(BC)患者的整体生活质量(QOL)。
将 BC 患者随机分为接受护士主导的 DT 干预(NDTI)常规筛查的痛苦组和常规护理(UC)组。两组患者在基线时、每次接受治疗后以及治疗结束后 2 年的随访时填写问卷。此时,干预组还接受了 NDTI。主要结局是 EORTC QLQ C30 在治疗结束后 2 年内的整体 QOL。使用协方差分析(ANCOVA)、广义最小二乘法和交互分析进行意向治疗分析。
在 194 名随机患者中,有 153 名患者在治疗结束后 2 年内填写了问卷。治疗结束后 2 年,NDTI 与 UC 在整体 QOL 方面没有显著差异(平均差值=-1.273,P=0.610;95%CI[-6.195;3.649])。对接受多模态治疗(手术、放疗和化疗,n=66)的患者进行亚组分析,显示整体 QOL 随时间存在显著的组间差异(平均差值=-10,P<.001;95%CI[-14.835;-5.167]),同时其他次要结局也有利于 NDTI。
NDTI 并未导致 BC 患者治疗结束后 2 年内整体 QOL 显著改善。然而,研究结果表明,接受多模态治疗的 BC 患者可能受益于 NDTI。